Survival: Clinical Trials

9 trials for Survival, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 recruiting, 2 unknown, 1 not yet recruiting. 9 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 39Completed 3, Recruiting 2, Unknown 2, Not yet recruiting 1, Withdrawn 1
Phase 22Not yet recruiting 1, Recruiting 1

Follow Survival: new trials by email Literature Review of Survival trials Research Report on Survival

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment
Brentuximab Vedotin for Injection, response-adapted radiation, Doxorubicin - Classical Hodgkin Lymphoma, Child
Phase 2 / Phase 3RecruitingChildren's Cancer Group, China962024-09-252026-03-19
An Open-label, Multicentre, Phase II/III RCT of PFLL Versus GP Combined With JS001 as the First-line Therapy for mNPC
Triprilimab(JS001), Cisplatin, 5-Fluorouracil - Nasopharyngeal Carcinoma, Metastasis
Phase 2 / Phase 3Not yet recruitingSun Yat-sen University6222021-07-012021-05-18
Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable Esophageal Carcinoma
Neoadjuvant immunochemotherapy - Esophageal Cancer, Surgery
Phase 3RecruitingHenan Cancer Hospital4002020-04-212022-10-04
Different Surgical Approaches in Patients of Early-stage Cervical Cancer
Laparotomic radical hysterectomy, Laparotomic radical trachelectomy, Laparoscopic radical hysterectomy - Uterine Cervical Neoplasm, Laparotomy
Phase 3UnknownLei Li7002018-11-232018-12-28
Perioperative Chemotherapy Combined With HIPEC for High-risk Advanced Gastric Cancer
Neoadjuvant chemotherapy, D2 radical resection, Hyperthermic intraperitoneal perfusion chemotherapy - Survival
Phase 3UnknownSixth Affiliated Hospital, Sun Yat-sen University6402016-11-012016-11-09
The Effect Of Aspirin On Survival in Lung Cancer
Aspirin 75 mg, no aspirin - Non Small Cell Lung Cancer, Survival
Phase 3WithdrawnLiverpool Heart and Chest Hospital NHS Foundation Trust2010-08-012016-03-07
Randomized Trial Comparing Sirolimus and Tacrolimus Versus Cyclosporine and Methotrexate as Graft-versus-host Disease (GVHD) Prophylaxis After Allogeneic Stem Cell Transplantation
Sirolimus/tacrolimus, cyclosporine/methotrexate - Graft-versus-host Disease, Survival
Phase 3CompletedKarolinska Institutet2152007-09-012015-04-14
Application of ATP Infusions in Palliative Home Care
Adenosine 5'-triphosphate - Cancer, Palliative Care
Phase 3CompletedMaastricht University Medical Center1002002-03-012016-10-25
Fluid Resuscitation With HES 200/0.5 10% in Severe Burn Injury
fluid resuscitation, Fluid resuscitation - Survival, Renal Failure
Phase 3CompletedUniversity of Zurich281997-04-012010-05-11

Narrower conditions

Carcinoma, Non-Small-Cell Lung (1)  ·  Esophageal Neoplasms (1)  ·  Graft vs Host Disease (1)  ·  Nasopharyngeal Carcinoma (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)  ·  Pelvic Floor Disorders (1)  ·  Renal Insufficiency (1)  ·  Stomach Neoplasms (1)  ·  Uterine Cervical Neoplasms (1)

Broader conditions

Neoplasms (5)  ·  Neoplasms by Site (5)  ·  Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Gastrointestinal Diseases (2)  ·  Gastrointestinal Neoplasms (2)  ·  Head and Neck Neoplasms (2)  ·  Male Urogenital Diseases (2)  ·  Urogenital Diseases (2)  ·  Bronchial Neoplasms (1)  ·  Carcinoma (1)  ·  Carcinoma, Bronchogenic (1)  ·  Esophageal Diseases (1)

Interventions

Adenosine Triphosphate (1)  ·  Aspirin (1)  ·  Brentuximab Vedotin (1)  ·  Chemotherapy, Adjuvant (1)  ·  Cisplatin (1)  ·  Cyclophosphamide (1)  ·  Cyclosporine (1)  ·  Dacarbazine (1)  ·  Doxorubicin (1)  ·  Etoposide (1)  ·  Fluorouracil (1)  ·  Gemcitabine (1)  ·  Injections (1)  ·  Methotrexate (1)  ·  N-acetyl-S-(alpha-methyl-4-(2-methylpropyl)benzeneacetyl)cysteine 4-(nitrooxy)butyl ester (1)

Sponsors

Children's Cancer Group, China (1)  ·  Henan Cancer Hospital (1)  ·  Karolinska Institutet (1)  ·  Lei Li (1)  ·  Liverpool Heart and Chest Hospital NHS Foundation Trust (1)  ·  Maastricht University Medical Center (1)  ·  Sixth Affiliated Hospital, Sun Yat-sen University (1)  ·  Sun Yat-sen University (1)  ·  University of Zurich (1)

Countries

China (5)  ·  Netherlands (1)  ·  Sweden (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Jun-Sheng Peng, PhD (1)  ·  Mike Mr Poullis, FRCS(CTh) (1)  ·  Olle Ringden, M.D. Ph.D. (1)  ·  P.C. Dagnelie, PhD (1)  ·  Yan Zheng, PhD, MD (1)  ·  Yun-fei Xia, MD (1)

Results publications

PMID 11813623, PMID 20584291, PMID 27662016, PMID 30710687, PMID 31362966, PMID 32502439, PMID 33317612, PMID 33553366, PMID 39221992, PMID 8156509